Comparison of timolol 0.5% + brimonidine 0.2% + dorzolamide 2% versus timolol 0.5% + brimonidine 0.2% in a Mexican population with primary open-angle glaucoma or ocular hypertension

BACKGROUND: The purpose of this study was to evaluate the efficacy and safety of two fixed combinations, ie, timolol 0.5% + brimonidine 0.2% + dorzolamide 2% (TBD) versus timolol 0.5% + brimonidine 0.2% (TB) in patients with primary open-angle glaucoma or ocular hypertension. METHODS: We performed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Baiza-Durán, Leopoldo Martín, Llamas-Moreno, Juan Francisco, Ayala-Barajas, Clotilde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402120/
https://www.ncbi.nlm.nih.gov/pubmed/22848147
http://dx.doi.org/10.2147/OPTH.S33578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402120/
https://www.ncbi.nlm.nih.gov/pubmed/22848147
http://dx.doi.org/10.2147/OPTH.S33578

Ejemplares similares